PFE | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Myovant Sciences Stock Rises After Pfizer Collaboration

Danny Abramov12/28/2020

3788

Myovant Sciences Ltd. (NYSE: MYOV) stock jumped more than 26% after the clinical-stage biopharmaceutical company announced a collaboration with Pfizer Inc. (NYSE: PFE) to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH)...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

The U.K. Approves Pfizer’s Covid Vaccine

Rebecca Urena12/03/2020

1607

Wednesday, the U.K. became the first country to approve Pfizer’s (NYSE: PFE) coronavirus vaccine for emergency use, and will begin administering shots in just a few days. The move...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech Report that Phase 3 Study of COVID-19 Vaccine Candidate Meets All Primary Efficacy Endpoints

Danny Abramov11/18/202011/18/2020

16349

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) made another announcement regarding their vaccine candidate. After conducting the final efficacy analysis in their ongoing Phase 3 study, their...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech SE Announce that COVID-19 Vaccine Candidate is 90% Effective

Danny Abramov11/09/202011/09/2020

9269

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced major news on Monday regarding their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2. The vaccine candidate has demonstrated evidence of efficacy against COVID-19...

Investing News Market News Technology

BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study

Danny Abramov07/20/2020

4310

BioNTech SE (NASDAQ: BNTX) and Pfizer Inc. (NYSE: PFE) announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global...

Healthcare Investing News Market News

Pfizer and Wellcome Launch Surveillance Program to Monitor Rising Danger of Antimicrobial Resistance in Sub-Saharan Africa

Danny Abramov06/24/2020

3651

Pfizer Inc. (NYSE: PFE) and Wellcome announced Wednesday the launch of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR), a new multi-year, public-private research collaboration...

Tag: PFE